Amerisource Health Services LLC recalls Meclizine Hydrochloride Tablets
- Published
- 1 Apr 2026
- Units affected
- 697 cartons
- Agency
- FDA
- Country
- United States
The hazard
Failed tablet specifications.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
- Brand / company
- Amerisource Health Services LLC
- Codes / lots
- Lot #1024852; Exp 9/30/2026
- Distribution
- U.S. Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 1 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.